When an influential federal advisory panel recommended in 2012 that doctors omit prostate cancer screening from routine health care for all men, it set off a firestorm, with urologists predicting an unconscionable death toll ...
Dec 9, 2020
0
12
(HealthDay)—The U.S. Food and Drug Administration approved the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer, the agency ...
Dec 3, 2020
0
3
Previous studies have shown that African American men are 2.4 times as likely to die from prostate cancer compared to non-Hispanic white men. This, plus a concern that African Americans may develop cancers that are more aggressive, ...
Nov 3, 2020
0
8
New research confirms the high impact of PSMA PET/CT in the detection and management of recurrent disease in prostate cancer patients. In initial results from a multicenter trial assessing the impact of 18F-DCFPyL prostate-specific ...
Jul 13, 2020
0
4
Many of the latest developments in the global coronavirus pandemic revolve around testing—for active infection and immunity. Diagnostic and antibody tests for COVID-19 and SARS-CoV-2 are flooding the market, as leaders ...
Jul 3, 2020
0
3
A new study finds rates of advanced prostate cancer continued to increase in men aged 50 and over in the United States, five years after the United States Preventive Services Task Force (USPSTF) recommended against prostate-specific ...
May 20, 2020
0
4
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced ...
Apr 9, 2020
0
163
Researchers at the Johns Hopkins Kimmel Cancer Center have made significant progress toward development of a simple, noninvasive liquid biopsy test that detects prostate cancer from RNA and other specific metabolic chemicals ...
Feb 28, 2020
0
329
Guidelines should change so that all men over the age of 40 with faults in the BRCA2 gene should be offered regular PSA testing to detect early signs of prostate cancer, experts are urging.
Nov 4, 2019
0
7
Getting a close look at the prostate is critical for detecting cancer, but its rather intimate positioning (just in front of the rectum) makes it difficult to image. Now, professor and chair of radiology Sanjiv "Sam" Gambhir, ...
Aug 29, 2019
0
124
